Ambit Partners with Datavant to Drive Innovation in ​​the Rare and Specialty Disease Markets​​
MORRISTOWN, NJ, September 19, 2023 – Ambit, a leading integrated biopharma solutions firm specializing in the rare and specialty disease markets, is pleased to announce a partnership with Datavant, the leader in...